Breast Pump denied as experimental or investigational by Aetna?

Aetna's specific coverage criteria for breast pump are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Labeled Your Breast Pump Experimental — and Why That's Likely Wrong

An "experimental or investigational" denial for a breast pump is highly atypical and almost certainly reflects either a coding error (e.g., the item was billed under an incorrect HCPCS code that triggered an experimental flag) or a policy-routing error. Breast pumps are not experimental medical devices; they have been commercially available and clinically endorsed for decades. More importantly, under the ACA's preventive-services mandate, non-grandfathered plans must cover breastfeeding support and supplies — including breast pumps — at no cost-sharing, based on HRSA Women's Preventive Services Guidelines. Applying an "experimental" classification to this benefit is likely a coverage error that can be corrected on appeal.

## Your Federal Appeal Rights

• Internal appeal: File within the timeframe on your EOB. Aetna must respond within 30 days (pre-service) or 60 days (post-service) of a complete appeal submission.
• External review (ACA §2719): After a final internal denial, you have approximately four months to request independent external review by a neutral organization.
• ACA preventive-services mandate: The HRSA Women's Preventive Services Guidelines explicitly include breastfeeding support and equipment. A denial on experimental grounds for a covered preventive benefit is subject to challenge under this framework.
• Expedited review: Available if delay poses an urgent clinical risk (e.g., newborn nutrition is affected).

## What to Gather

1. The denial letter — obtain the full text and identify the exact basis: which policy provision classifies a breast pump as experimental, and what HCPCS or CPT code was used in the claim. 2. Corrected billing information — if the denial appears to stem from a coding error, work with the DME supplier to identify and resubmit the correct code. 3. ACA preventive-services citation — reference the HRSA Women's Preventive Services Guidelines and the ACA's requirement that breast pumps be covered as a preventive service. 4. Clinician's letter — if the pump was prescribed for a specific medical condition (e.g., NICU admission, mastitis), include documentation of medical necessity to provide an independent coverage basis. 5. Aetna's breast pump and DME policy — download the current version to verify whether any "experimental" provision was legitimately applied.

## Criteria-Mapping Structure

Challenge the experimental classification directly: identify the definition of "experimental or investigational" in Aetna's policy and demonstrate, point by point, that a breast pump does not meet that definition. Supplement with the ACA preventive-services mandate as an independent basis for coverage regardless of the experimental classification.

## Bottom Line

An experimental denial for a breast pump is almost always a classification error. A short, well-documented appeal citing the ACA mandate and challenging the applicability of the experimental provision to this item routinely resolves these denials.